Dupixent (dupilumab) is a biologic drug approved by the FDA for treating prurigo nodularis (PN). It reduces inflammation by blocking interleukin-4 (IL-4) receptors, helping to relieve itching and improve skin symptoms. It's administered as an injection, starting with a larger dose followed by maintenance doses every two Show Full Answer

Dupixent (dupilumab) is a biologic drug approved by the FDA for treating prurigo nodularis (PN). It reduces inflammation by blocking interleukin-4 (IL-4) receptors, helping to relieve itching and improve skin symptoms. It's administered as an injection, starting with a larger dose followed by maintenance doses every two weeks. For more, visit: [Dupixent for Prurigo Nodularis](https://www.MyPrurigoTeam.com/treatments/dupixent).

 This AI-generated response comes from MyPrurigoTeam and other selected sources. It is not a substitute for medical advice. Always ask your doctor about specific health concerns.

Dupixent (Dupilumab) for Prurigo Nodularis | MyPrurigoTeam

Is Prurigo Nodularis an Autoimmune Disease? | MyPrurigoTeam